Ren X - Search Results

1

First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data.

Sheng X, Bi F, Ren X, Cheng Y, Wang J, Rosbrook B, Jiang M, Guo J. Sheng X, et al. Among authors: ren x. Future Oncol. 2019 Jan;15(1):53-63. doi: 10.2217/fon-2018-0442. Epub 2018 Jul 30. Future Oncol. 2019. PMID: 30058839 Clinical Trial.

2

A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanoma.

Cui C, Mao L, Chi Z, Si L, Sheng X, Kong Y, Li S, Lian B, Gu K, Tao M, Song X, Lin T, Ren X, Qin S, Guo J. Cui C, et al. Among authors: ren x. Mol Ther. 2013 Jul;21(7):1456-63. doi: 10.1038/mt.2013.79. Epub 2013 May 14. Mol Ther. 2013. PMID: 23670576 Free PMC article. Clinical Trial.

3

Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer.

Zheng XQ, Guo JP, Yang H, Kanai M, He LL, Li YY, Koomen JM, Minton S, Gao M, Ren XB, Coppola D, Cheng JQ. Zheng XQ, et al. Among authors: ren xb. Oncogene. 2014 Oct 16;33(42):4985-96. doi: 10.1038/onc.2013.444. Epub 2013 Oct 28. Oncogene. 2014. Retraction in: Oncogene. 2024 Apr;43(15):1160. doi: 10.1038/s41388-024-02983-9 PMID: 24166501 Free PMC article. Retracted.

4

A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.

Yu X, Zhao H, Liu L, Cao S, Ren B, Zhang N, An X, Yu J, Li H, Ren X. Yu X, et al. Among authors: ren x, ren b. J Clin Immunol. 2014 Feb;34(2):194-203. doi: 10.1007/s10875-013-9976-0. Epub 2013 Dec 15. J Clin Immunol. 2014. PMID: 24337625 Clinical Trial.

5

Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study.

Qin S, Bi F, Jin J, Cheng Y, Guo J, Ren X, Huang Y, Tarazi J, Tang J, Chen C, Kim S, Ye D. Qin S, et al. Among authors: ren x. Onco Targets Ther. 2015 Jun 8;8:1363-73. doi: 10.2147/OTT.S83302. eCollection 2015. Onco Targets Ther. 2015. PMID: 26089686 Free PMC article.

6

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Guo J, Qin S, Liang J, Lin T, Si L, Chen X, Chi Z, Cui C, Du N, Fan Y, Gu K, Li F, Li J, Li Y, Liang H, Liu J, Lu M, Lu A, Nan K, Niu X, Pan H, Ren G, Ren X, Shu Y, Song X, Tao M, Wang B, Wei W, Wu D, Wu L, Wu A, Xu X, Zhang J, Zhang X, Zhang Y, Zhu H; written on behalf of Chinese Society of Clinical Oncology (CSCO) Melanoma Panel. Guo J, et al. Among authors: ren g, ren x. Chin Clin Oncol. 2016 Aug;5(4):57. doi: 10.21037/cco.2015.12.02. Epub 2015 Dec 17. Chin Clin Oncol. 2016. PMID: 27164849 Free article. No abstract available.

7

Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer.

Han Y, Wang J, Hong L, Sun L, Zhuang H, Sun B, Wang H, Zhang X, Ren X. Han Y, et al. Among authors: ren x. Future Oncol. 2017 Jan;13(1):51-61. doi: 10.2217/fon-2016-0317. Epub 2016 Aug 15. Future Oncol. 2017. PMID: 27523323

8

[Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment].

Wang X, Zhang W, Du W, Zhang X, Ren X, Cao S. Wang X, et al. Among authors: ren x. Zhongguo Fei Ai Za Zhi. 2017 Nov 20;20(11):761-768. doi: 10.3779/j.issn.1009-3419.2017.11.07. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29167006 Free PMC article. Chinese.

9

Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma.

Qin SK, Jin J, Guo J, Wang JW, Zhou FJ, Huang YR, Ren XB, Ye DW, Pan S, Sajben P, Wang Q. Qin SK, et al. Future Oncol. 2018 Aug;14(18):1835-1845. doi: 10.2217/fon-2017-0733. Epub 2018 May 2. Future Oncol. 2018. PMID: 29717651 Clinical Trial.

10

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial.

Zhou AP, Bai Y, Song Y, Luo H, Ren XB, Wang X, Shi B, Fu C, Cheng Y, Liu J, Qin S, Li J, Li H, Bai X, Ye D, Wang J, Ma J. Zhou AP, et al. Among authors: ren xb. Oncologist. 2019 Aug;24(8):e702-e708. doi: 10.1634/theoncologist.2018-0839. Epub 2019 Mar 22. Oncologist. 2019. PMID: 30902918 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,065 results

Search Page

Filters